SAVIENT PHARMACEUTICALS INC
SVNT
SVNT was delisted on the 16th of October, 2013.
7 hedge funds and large institutions have $5K invested in SAVIENT PHARMACEUTICALS INC in 2013 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 34 closing their positions.
83% less funds holding
Funds holding: 41 → 7 (-34)
95% less call options, than puts
Call options by funds: $3K | Put options by funds: $62K
97% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 34
100% less capital invested
Capital invested by funds: $13M → $5K (-$13M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Group One Trading
Chicago,
Illinois
|
+$52.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$5.46M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$2.31M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.08M |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$1.4M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$450K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
JP Morgan Chase
New York
| – | -$11K | -18,477 | Closed |
|
|
FIM
27
Freedom Investment Management
Hartford,
Connecticut
| – | -$10K | -16,808 | Closed |
|
|
BA
28
BlackRock Advisors
Wilmington,
Delaware
| – | -$8K | -12,887 | Closed |
|
|
RFC
29
Russell Frank Company
Seattle,
Washington
| – | -$7K | -11,590 | Closed |
|
|
AL
30
Airain Ltd
St. Peter Port,
Guernsey
| – | -$6K | -10,200 | Closed |
|
31
Bank of America
Charlotte,
North Carolina
| – | -$6K | -9,690 | Closed |
|
|
CPA
32
Cowen Prime Advisors
New York
| – | -$3K | -5,450 | Closed |
|
33
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| – | -$2 | -2,469 | Closed |
|
|
TRCT
34
Tower Research Capital (TRC)
New York
| – | -$1K | -1,923 | Closed |
|
35
Wells Fargo
San Francisco,
California
| – | -$1K | -1,800 | Closed |
|
36
Fayez Sarofim & Co
Houston,
Texas
| – | +$7.02K | +13,860 | New |
|
SVNT Hedge Fund Activity: Q4 2013 in Review
7 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in SAVIENT PHARMACEUTICALS INC (SVNT) for Q4 2013, worth a combined $5K — down 100% from $13M a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of SVNT and 1 opened new positions — a net loss of 33 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Group One Trading, adding an estimated $52.4K. The largest seller was Palo Alto Investors, exiting entirely with an estimated $5.46M sold.
- 7 institutional investors held SAVIENT PHARMACEUTICALS INC (SVNT) as of Q4 2013, down from 41 in Q3 2013.
- Funds reported $5K of SAVIENT PHARMACEUTICALS INC stock for Q4 2013, down 100% quarter-over-quarter.
- 1 fund opened new SAVIENT PHARMACEUTICALS INC positions in Q4 2013 and 34 closed out, a net change of -33 holders.
- The largest SAVIENT PHARMACEUTICALS INC buyer in Q4 2013 was Group One Trading, an estimated $52.4K added.
- The largest SAVIENT PHARMACEUTICALS INC seller in Q4 2013 was Palo Alto Investors, an estimated $5.46M sold.
Based on aggregated 13F filings for Q4 2013.